|
End-of-day quote
Buenos Aires S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 1,305.00 ARS | +0.38% |
|
-3.33% | -33.92% |
| Market Cap | 105B 68.52M 61.36M 56.45M 51.14M 95.6M 6.51B 97.39M 673M 270M 3.42B 257M 252M 10.79B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 336B 219M 196M 180M 163M 305M 20.77B 311M 2.15B 863M 10.93B 821M 803M 34.45B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
Buenos Aires S.E.ARS
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| RICH | End-of-day quote | |
Buenos Aires S.E.
| RICHD | End-of-day quote |
| 1 day | +0.38% | ||
| 1 week | -3.33% | ||
| 1 month | -6.12% | ||
| 3 months | -15.81% | ||
| 6 months | -20.18% | ||
| Current year | -33.92% |
| 1 week | 1,290 | 1,390 | |
| 1 month | 1,290 | 1,580 | |
| Current year | 1,290 | 2,130 | |
| 1 year | 1,290 | 2,300 | |
| 3 years | 595.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 29/04/2025 | |
| Corporate Officer/Principal | - | 29/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.38% | -3.33% | -18.18% | +94.78% | 68.52M | ||
| +3.19% | +11.31% | +64.28% | +155.66% | 1,263B | ||
| -0.73% | +3.56% | +44.65% | +83.74% | 658B | ||
| +1.41% | +3.24% | +35.25% | +106.98% | 521B | ||
| -1.33% | +0.30% | +53.26% | +67.00% | 391B | ||
| +2.18% | +2.93% | +73.90% | +45.38% | 369B | ||
| -1.31% | +3.59% | +32.72% | +55.99% | 307B | ||
| -0.56% | +8.12% | +12.41% | +34.12% | 290B | ||
| +1.15% | +6.09% | +56.15% | +78.66% | 252B | ||
| +3.06% | +9.38% | +42.48% | +112.84% | 212B | ||
| Average | +0.27% | +5.19% | +39.69% | +83.51% | 426.2B | |
| Weighted average by Cap. | +0.26% | +6.60% | +50.16% | +98.80% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 59.68M 53.45M 49.17M 44.55M 83.28M 5.67B 84.83M 586M 235M 2.98B 224M 219M 9.4B | 127B 82.4M 73.79M 67.88M 61.5M 115M 7.82B 117M 809M 325M 4.12B 309M 303M 12.98B |
| Net income | 23.85B 15.5M 13.89M 12.77M 11.57M 21.63M 1.47B 22.04M 152M 61.14M 774M 58.18M 56.95M 2.44B | 3.09B 2.01M 1.8M 1.65M 1.5M 2.8M 191M 2.85M 19.72M 7.92M 100M 7.53M 7.37M 316M |
| Net Debt | 134B 86.9M 77.82M 71.59M 64.86M 121M 8.25B 124M 854M 343M 4.34B 326M 319M 13.69B | 231B 150M 135M 124M 112M 210M 14.26B 214M 1.48B 592M 7.5B 564M 552M 23.66B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ARS 1,305.00 | +0.38% | 693 |
| 29/10/26 | ARS 1,300.00 | -5.80% | 982 |
| 28/10/26 | ARS 1,380.00 | +6.98% | 784 |
| 27/10/26 | ARS 1,290.00 | -2.27% | 993 |
| 26/10/26 | ARS 1,320.00 | -2.22% | 407 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions

















